A significant advance in cancer study is arising with the use of VHH fragments to re-engage mutated p53. This vital tumor inhibitor protein is frequently inactivated in many kinds of cancer, resulting uncontrolled cell https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research